Atherogenic properties of lipoproteins in HIV patients starting atazanavir/ritonavir or darunavir/ritonavir: a substudy of the ATADAR randomized study
Saumoy, M., Ordonez-Llanos, J., Martinez, E., Ferrer, E., Domingo, P., Ribera, E., Negredo, E., Curto, J., Sanchez-Quesada, J. L., Di Yacovo, S., Gonzalez-Cordon, A., Podzamczer, D.Language:
english
Journal:
Journal of Antimicrobial Chemotherapy
DOI:
10.1093/jac/dku501
Date:
December, 2014
File:
PDF, 393 KB
english, 2014